FDA Advisers Recommend Approval of Breast Cancer Drug (FREE)

By the Editors An advisory panel recommended on Wednesday that the FDA approve the breast cancer drug neratinib (to be marketed as Nerlynx), …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news